Hepatopulmonary syndrome: An update

查看全文 作　　者：Kejal D [1]Gandhi;Pahnwat Tonya [2]Taweesedt;Munish [2]Sharma;Salim [3,4]Surani

机构地区：[1]Department of Internal Medicine,Medstar Washington Hospital Center/Georgetown University,Washigton,DC 20010,United States;[2]Department of Medicine,Corpus Christi Medical Center,Corpus Christi,TX 78412,United States;[3]Department of Medicine,Texas A&M University,Bryan,TX 78413,United States;[4]Department of Anesthesiology,Mayo Clinic,Rochester,MN 55905,United States

出　　处：《World Journal of Hepatology》索引2021年第13卷第11期,共8页

摘　　要：Hepatopulmonary syndrome(HPS)is characterized by defects in oxygenation caused by intra-pulmonary vasodilation occurring because of chronic liver disease,portal hypertension,or congenital portosystemic shunts.Clinical implications of portal hypertension are very well-known,however,awareness of its effect on multiple organs such as the lungs are less known.The presence of HPS in chronic liver disease is associated with increased mortality.Medical therapies available for HPS have not been proven effective and definitive treatment for HPS is mainly liver transplantation(LT).LT improves mortality for patients with HPS drastically.This article provides a review on the definition,clinical presentation,diagnosis,and management of HPS. 关键词：Hepatopulmonary syndrome Chronic liver disease HYPOXEMIA Intrapulmonary vasodilatation Liver failure

相关文献

参考文献（47）
引证文献（4）
耦合文献（48）

参考文献(47)

引证文献(4)

耦合文献(48)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

Hepatopulmonary syndrome: An update

参考文献(47)

引证文献(4)

耦合文献(48)

用户提示